Date published: 2026-3-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

IL-33 Inhibitors

IL-33 inhibitors belong to a class of chemical compounds designed to target and interfere with the activity of Interleukin-33 (IL-33), a cytokine that plays a crucial role in immune and inflammatory responses within the body. IL-33 is a member of the IL-1 family and is produced by various cell types, particularly in response to tissue damage or inflammation. It acts as an alarmin, a molecule released by damaged cells to signal the immune system and initiate a response. IL-33 binds to its receptor, ST2, which is expressed on various immune cells, leading to the activation of signaling pathways that can contribute to immune reactions and inflammation. IL-33 is involved in the regulation of immune cell recruitment, cytokine production, and tissue repair processes. IL-33 inhibitors are designed to modulate or block these interactions between IL-33 and its receptor, potentially influencing the downstream immune responses and inflammatory cascades.

The development of IL-33 inhibitors is driven by the need to better understand the complex immune processes and inflammatory conditions in which IL-33 is implicated. By targeting IL-33, these inhibitors offer researchers a valuable tool for investigating the specific roles of IL-33 in various physiological and pathological contexts. They can provide insights into the intricate signaling pathways that govern immune responses and may have implications for conditions characterized by excessive inflammation.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Curcumin inhibits IL-33 expression by blocking NF-κB activation and reducing inflammatory responses.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Resveratrol may inhibit IL-33 via downregulation of pro-inflammatory cytokines, limiting its release.

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$110.00
$250.00
$936.00
$50.00
33
(2)

Quercetin suppresses IL-33 by interfering with NF-κB signaling and modulating immune responses.

D,L-Sulforaphane

4478-93-7sc-207495A
sc-207495B
sc-207495C
sc-207495
sc-207495E
sc-207495D
5 mg
10 mg
25 mg
1 g
10 g
250 mg
$153.00
$292.00
$489.00
$1325.00
$8465.00
$933.00
22
(1)

Sulforaphane hinders IL-33 production through its anti-inflammatory and antioxidant properties.

Baicalein

491-67-8sc-200494
sc-200494A
sc-200494B
sc-200494C
10 mg
100 mg
500 mg
1 g
$32.00
$42.00
$162.00
$292.00
12
(1)

Baicalein inhibits IL-33 expression by interfering with MAPK pathways, reducing cytokine release.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

EGCG may suppress IL-33 via modulation of NF-κB, curbing the inflammatory response.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Genistein can inhibit IL-33 expression by disrupting JAK/STAT signaling and cytokine release.

Berberine

2086-83-1sc-507337
250 mg
$92.00
1
(0)

Berberine may inhibit IL-33 by reducing NF-κB activation, thus dampening the inflammatory process.

Luteolin

491-70-3sc-203119
sc-203119A
sc-203119B
sc-203119C
sc-203119D
5 mg
50 mg
500 mg
5 g
500 g
$27.00
$51.00
$101.00
$153.00
$1925.00
40
(1)

Luteolin suppresses IL-33 through inhibition of the NF-κB pathway and modulation of immune responses.

Apigenin

520-36-5sc-3529
sc-3529A
sc-3529B
sc-3529C
sc-3529D
sc-3529E
sc-3529F
5 mg
100 mg
1 g
5 g
25 g
100 g
1 kg
$33.00
$214.00
$734.00
$1151.00
$2348.00
$3127.00
$5208.00
22
(1)

Apigenin may inhibit IL-33 expression by interfering with JNK pathways and reducing cytokine production.